Lialiaris Theodore S, Kouskoukis Alexandros, Georgiou Georgios, Tripsianis Gregory, Fiska Aliki, Giatromanolaki Alexandra, Chrisafi Sofia, Sivridis Efthimios, Vamvakopoulou Dimitra N, Soutopoulou Despina O, Kiritsaka Aspasia, Athanassiou Evangelos, Lialios Georgios A, Sotiriou Sotirios, Sidiropoulos Andreas, Vamvakopoulos Nicholas C
Department s of Genetics, Demokrition University of Thrace, Medical School, Alexandroupolis, Greece.
Appl Immunohistochem Mol Morphol. 2011 Mar;19(2):106-11. doi: 10.1097/PAI.0b013e3181e181b1.
Expression of estrogen (ER) and progesterone receptors, c-erbB-2 oncogene, mutant p53 antioncogene (mp53), e-cadherin adhesion, and apoptotic caspase-8 antigens in tumor relative to matched normal tissue specimens from 102 unselected patients with primary ductal breast carcinoma of various tumor grades was assessed by immunohistochemistry and correlated with patient's biologic and clinical features, such as age, menstrual status, age of menarche, tumor grade and diameter, the presence or absence of metastases, and number of infiltrated lymph nodes. We observed association of e-cadherin adhesion, ER and progesterone antigen marker expression with low histologic grade tumors and limited number of lymph node metastases and of c-erbB-2, mp53, and casp-8 antigen marker expression with high histologic grade tumors and increased number of lymph node metastases. We also observed strong correlation (P<0.05) between 4 of the 6 biomarkers and 4 of the 7 patient/tumor parameters examined. Our findings support the hypothesis of independent expression of these 4 strong biomarkers and reveal that nearly 40% of all breast tumor cases studied express similar proportions of 2 major phenotypic combinations [ER/c-erbB-2/mp53/casp-8: +/+/-/+ (19.6%) & +/-/-/+ (17.8%)]. We conclude that, in agreement with earlier reports, our findings support the diagnostic and potential prognostic value of these markers in the clinical assessment of breast cancer.
通过免疫组织化学方法评估了102例未经选择的不同肿瘤分级的原发性导管乳腺癌患者肿瘤组织及配对正常组织标本中雌激素(ER)和孕激素受体、c-erbB-2癌基因、突变型p53抗癌基因(mp53)、E-钙黏蛋白黏附分子及凋亡相关半胱天冬酶-8抗原的表达情况,并将其与患者的生物学和临床特征进行关联分析,这些特征包括年龄、月经状态、初潮年龄、肿瘤分级和直径、有无转移以及浸润淋巴结数量。我们观察到E-钙黏蛋白黏附分子、ER和孕激素抗原标志物表达与低组织学分级肿瘤以及有限的淋巴结转移数量相关,而c-erbB-2、mp53和半胱天冬酶-8抗原标志物表达与高组织学分级肿瘤以及增加的淋巴结转移数量相关。我们还观察到6种生物标志物中的4种与所检测的7种患者/肿瘤参数中的4种之间存在强相关性(P<0.05)。我们的研究结果支持这4种强生物标志物独立表达的假说,并揭示在所研究的所有乳腺肿瘤病例中,近40%表达两种主要表型组合[ER/c-erbB-2/mp53/casp-8:+/+/ - / +(19.6%)和+/-/- / +(17.8%)]的比例相似。我们得出结论,与早期报告一致,我们的研究结果支持这些标志物在乳腺癌临床评估中的诊断和潜在预后价值。